awards grant
- 18F-PU-AD epichaperome PET to characterize and diagnose AD and ADRD
- A telehealth intervention to improve initiation of mental health treatment among depressed older adults with cancer
- Autoimmune Stem-like CD8 T cells in Type I Diabetes
- Bridging predictive models and precision immunotherapies
- Communicating the gist of prognosis: An intervention to improve prognostic understanding in advanced lymphoma
- Developing Novel Therapeutic Approaches for Classical and Variant Hairy Cell Leukemia (Core 2)
- Developing Novel Therapeutic Approaches for Classical and Variant Hairy Cell Leukemia (Project 1)
- Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling
- Directing Fate, Subtype Identity And Survival In Human Pluripotent-Derived Midbrain Dopamine Neurons
- Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens
- Epigenetic regulation of CIN in TNBC metastasis
- Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
- Identifying synthetically lethal compounds for therapy of homologous recombination deficient (HRD) breast cancers
- Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
- MSK Immuno-Oncology for the Translational Researcher Short Course
- MSK SPORE in Genomic Instability in Breast Cancer: Project 2
- Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
- Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL)
- TOX-driven CD8 T cell differentiation and dysfunction in tumors - R01CA269733. (PA-20-185)
- Targeting immune evasion in gastroesophageal cancer
- Translational Discovery in Peripheral T-Cell Lymphomas
- Tumor-Selective Delivery Approaches for Medulloblastoma
- Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
- Value Proposition & Market" and "Applicability to Future Infectious Disease Threats